Frequency and Phenotype of Infected Clones
| Patient . | Virus . | Diagnosis . | Infected Clones/Total Clones . | Phenotype . | ||
|---|---|---|---|---|---|---|
| . | . | . | . | CD4 . | CD8 . | ND . |
| Pr | HTLV-I | TSP | 8/24 (33%)* | — | — | 8 |
| Du | HTLV-I | TSP | 7/40 (17%) | 5 | 1 | 1 |
| Mu | HTLV-I | TSP | 4/20 (20%) | 4 | 0 | — |
| Ph | HTLV-I | NSP | 1/9 (11%) | 0 | 1 | — |
| CP | HTLV-I | polymyositis | 3/20 (15%) | 3 | 0 | — |
| RM | HTLV-I | ASX | 1/30 (3%) | — | — | 1 |
| RB | HTLV-II | ASX† | 0/162 (<1%) | — | — | — |
| Patient . | Virus . | Diagnosis . | Infected Clones/Total Clones . | Phenotype . | ||
|---|---|---|---|---|---|---|
| . | . | . | . | CD4 . | CD8 . | ND . |
| Pr | HTLV-I | TSP | 8/24 (33%)* | — | — | 8 |
| Du | HTLV-I | TSP | 7/40 (17%) | 5 | 1 | 1 |
| Mu | HTLV-I | TSP | 4/20 (20%) | 4 | 0 | — |
| Ph | HTLV-I | NSP | 1/9 (11%) | 0 | 1 | — |
| CP | HTLV-I | polymyositis | 3/20 (15%) | 3 | 0 | — |
| RM | HTLV-I | ASX | 1/30 (3%) | — | — | 1 |
| RB | HTLV-II | ASX† | 0/162 (<1%) | — | — | — |